JP2023526247A5 - - Google Patents
Info
- Publication number
- JP2023526247A5 JP2023526247A5 JP2022568792A JP2022568792A JP2023526247A5 JP 2023526247 A5 JP2023526247 A5 JP 2023526247A5 JP 2022568792 A JP2022568792 A JP 2022568792A JP 2022568792 A JP2022568792 A JP 2022568792A JP 2023526247 A5 JP2023526247 A5 JP 2023526247A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063024442P | 2020-05-13 | 2020-05-13 | |
| US63/024,442 | 2020-05-13 | ||
| PCT/US2021/031989 WO2021231572A1 (en) | 2020-05-13 | 2021-05-12 | Pyridazinone compounds for the treatment of neuromuscular diseases |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023526247A JP2023526247A (ja) | 2023-06-21 |
| JP2023526247A5 true JP2023526247A5 (https=) | 2024-05-22 |
| JPWO2021231572A5 JPWO2021231572A5 (https=) | 2024-05-22 |
| JP7758687B2 JP7758687B2 (ja) | 2025-10-22 |
Family
ID=76444536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568792A Active JP7758687B2 (ja) | 2020-05-13 | 2021-05-12 | 神経筋疾患の処置のためのピリダジノン化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230150977A1 (https=) |
| EP (1) | EP4149621B1 (https=) |
| JP (1) | JP7758687B2 (https=) |
| WO (1) | WO2021231572A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3877376T3 (da) | 2018-11-06 | 2023-10-02 | Edgewise Therapeutics Inc | Pyridazinonforbindelser og anvendelser deraf |
| CA3118908A1 (en) | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| AU2019374812B2 (en) | 2018-11-06 | 2025-03-06 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| CN120302976A (zh) | 2022-09-09 | 2025-07-11 | 艾知怀斯治疗学公司 | 用于治疗神经肌肉病状的哒嗪酮组合物 |
| KR20250121977A (ko) * | 2023-01-04 | 2025-08-12 | 시젱 하이스코 파마수티칼 씨오., 엘티디. | 피리다지논 헤테로사이클릭 화합물 Myosin II 억제제 및 이의 용도 |
| WO2025153721A1 (en) * | 2024-01-19 | 2025-07-24 | Scenic Biotech Bv | Pla2g15 inhibitors |
| WO2025167826A1 (zh) * | 2024-02-06 | 2025-08-14 | 西藏海思科制药有限公司 | 三环化合物作为Myosin II抑制剂及其用途 |
| WO2025175141A1 (en) * | 2024-02-16 | 2025-08-21 | Cytokinetics, Incorporated | Fast skeletal muscle myosin inhibitors |
| WO2025242154A1 (zh) * | 2024-05-23 | 2025-11-27 | 西藏海思科制药有限公司 | 哒嗪酮衍生物及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| CN1087725C (zh) | 1994-03-25 | 2002-07-17 | 同位素技术有限公司 | 用氘代方法增强药物效果 |
| NZ522882A (en) * | 2000-06-05 | 2004-07-30 | Altana Pharma Bv | Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors |
| UA95644C2 (ru) * | 2006-07-25 | 2011-08-25 | Сефалон, Инк. | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний |
| AU2008219166B2 (en) * | 2007-02-16 | 2013-05-16 | Amgen Inc. | Nitrogen-containing heterocyclyl ketones and their use as c-Met inhibitors |
| AR081331A1 (es) * | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US8759380B2 (en) * | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
| EP3600322A1 (en) * | 2017-03-28 | 2020-02-05 | Boehringer Ingelheim International GmbH | Nintedanib for use in methods for the treatment of muscular dystrophy |
| EP3700516B1 (en) * | 2017-10-27 | 2024-01-24 | Sonic Master Limited | Inhibitors of dux4 induction for regulation of muscle function |
| EP4685140A1 (en) * | 2018-06-04 | 2026-01-28 | Ohio State Innovation Foundation | Eaat2 activators and methods of using thereof |
| CA3118908A1 (en) * | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| AU2019374812B2 (en) * | 2018-11-06 | 2025-03-06 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| DK3877376T3 (da) * | 2018-11-06 | 2023-10-02 | Edgewise Therapeutics Inc | Pyridazinonforbindelser og anvendelser deraf |
-
2021
- 2021-05-12 EP EP21732618.0A patent/EP4149621B1/en active Active
- 2021-05-12 WO PCT/US2021/031989 patent/WO2021231572A1/en not_active Ceased
- 2021-05-12 JP JP2022568792A patent/JP7758687B2/ja active Active
-
2022
- 2022-11-07 US US18/053,326 patent/US20230150977A1/en active Pending